Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
Crossref DOI link: https://doi.org/10.1007/s12072-023-10634-6
Published Online: 2024-01-22
Published Print: 2024-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Teng, Wei
Chang, Ting‑Tsung
Yang, Hwai‑I
Peng, Cheng‑Yuan
Su, Chien‑Wei
Su, Tung‑Hung
Hu, Tsung‑Hui
Yu, Ming‑Lung
Yang, Hung‑Chih
Wu, Jaw‑Ching
Text and Data Mining valid from 2024-01-22
Version of Record valid from 2024-01-22
Article History
First Online: 22 January 2024
Free to read: This content has been made available to all.